1093

How is 1093 doing right now?

In plain terms: 1093 is 38.2% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

CSPC Pharmaceutical Group (1093) sits 38.2% off its peak and is currently in a severe drawdown, last printing at $6.99. A 35-60% drawdown is the territory where most retail investors capitulate. It's also where the highest-probability historical entries have clustered for resilient assets.

What history says at this drawdown

Across all available history, 1093 has spent enough trading days in the 40%-to-35% drawdown band to build a large sample (449 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

What this means for 1093

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to 1093's own volatility history. Severe drawdowns are where Dipsern's segmentation provides the most edge: ordinary base rates don't apply, but the asset's own history at this exact depth does. The forward-return distribution here is bimodal — either rapid recovery or continued decline.